9th Sep 2020 14:28
(Alliance News) - MaxCyte Inc on Wednesday said Amanda Murphy has joined the company as chief financial officer.
Ron Holtz, who has served as MaxCyte's CFO since 2005, will become senior vice president & chief accounting officer.
The biotechnology company said Murphy served as a managing director of BTIG LLC before joining MaxCyte. Prior to BTIG, she was a partner & healthcare analyst at William Blair & Co, focused on diagnostic services and life sciences.
"We are extremely pleased to welcome Amanda, who served as a successful, respected analyst in both the enabling technology and cell therapy sectors, to the MaxCyte team at this pivotal moment for the company and the industry," said President & Chief Executive Doug Doerfler.
The stock was trading 0.5% lower in London on Wednesday at 328.44 pence a share.
By Evelina Grecenko; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
MaxCyte